Order Article Reprints

Hirte H, Yao X, Ferguson SE, May T, Elit L. An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma. Current Oncology. 2021; 28(2):1114-1124. https://doi.org/10.3390/curroncol28020107

Hirte, Hal, Xiaomei Yao, Sarah E. Ferguson, Taymaa May, and Laurie Elit. 2021. "An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma" Current Oncology 28, no. 2: 1114-1124. https://doi.org/10.3390/curroncol28020107

Hirte, H., Yao, X., Ferguson, S. E., May, T., & Elit, L. (2021). An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma. Current Oncology, 28(2), 1114-1124. https://doi.org/10.3390/curroncol28020107